Surge in VC funding, dealmaking will improve biotech drug pipeline

06/20/2014 | Genetic Engineering & Biotechnology News

The recent uptick in venture capital investments in the biotechnology sector and the increasing number of partnerships between large and smaller biotech firms should help drugmakers replenish their pipeline and come up with better products in the future. Data from a Moneytree report showed that the biotech industry secured more than $4 billion in venture capital investments last year, an 8% growth, making it the second-biggest investment sector for venture capitalists for the year.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Chief Medical Officer
Nashville, TN
Commercial Health Insurance Strategist__Job #52-14
American Academy of Family Physicians
Leawood, KS
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC